The major objective of this project is to identify biological processes and radiochemical tracers ulitmately useful in nuclear imaging of tumors and to use this information in tumor diagnosis as well as the monitoring of response to fractionated radiation therapy. Biological processes which are quantitatively different, but not qualitatively unique, in tumors will be investigated, using mouse tumor and cell culture systems.
The specific aims are as follows. (1) The biological basis for uptake of the tumor imaging radionuclide gallium-67 in control and irradiated tumor cells in vitro and tumors in vivo via a transferrin (Tf) receptor will be studied, testing the hypotheses that growth state is the principal determinent of Tf receptor number; postradiation growth changes may alter number of cell surface Tf receptors; and Tf-mediated uptake of iron is a major competitor in gallium-67 uptake. (2) The metabolically induced binding of labelled hypoxic cell radiation sensitizing drugs in hypoxic cells will be studied as a basis for imaging radiation resistent, oxygen-deprived tumor regions. (3) Uptake of labelled DNA and glycolysis precurosors will be investigated as an indicator of the feasibility of positron imaging of tumors. These biological phenomena are chosen for two reasons. First, tumors are likely to differ quantitatively from many normal tissues in having increased cell proliferation (higher DNA synthesis rates, more cell surface Tf receptors), increased glycolysis, and a proportion of hypoxic cells. Second, the concept of """"""""metabolic trapping"""""""" applies to certain precursors of DNA synthesis and glycolysis and probably to the hypoxic cell sensitizers as well. Repopulation of tumor cells between doses of radiation and reoxygenation of formerly hypoxic cells are two major modifiers of tumor response to fractionated radiotherapy and these phenomena are amenable to study by the approaches outlined above.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA034570-03
Application #
3172294
Study Section
(SSS)
Project Start
1983-04-01
Project End
1987-02-28
Budget Start
1985-03-01
Budget End
1986-02-28
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Schwartz, Jeffrey L; Tamura, Yasuko; Jordan, Robert et al. (2004) Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3'-deoxy-3'fluorothymidine uptake. Nucl Med Biol 31:419-23
Grierson, John R; Schwartz, Jeffery L; Muzi, Mark et al. (2004) Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography. Nucl Med Biol 31:829-37
Rajendran, J G; Wilson, D C; Conrad, E U et al. (2003) [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging 30:695-704
Schwartz, Jeffrey L; Tamura, Yasuko; Jordan, Robert et al. (2003) Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs. J Nucl Med 44:2027-32
Schwartz, J L; Rasey, J; Wiens, L et al. (1999) Functional inactivation of p53 by HPV-E6 transformation is associated with a reduced expression of radiation-induced potentially lethal damage. Int J Radiat Biol 75:285-91
Tewson, T J (1997) Synthesis of [18F]fluoroetanidazole: a potential new tracer for imaging hypoxia. Nucl Med Biol 24:755-60
Caldwell, J H; Revenaugh, J R; Martin, G V et al. (1995) Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia. J Nucl Med 36:1633-8
Casciari, J J; Graham, M M; Rasey, J S (1995) A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. Med Phys 22:1127-39
Casciari, J J; Chin, L K; Livesey, J C et al. (1995) Growth rate, labeling index, and radiation survival of cells grown in the Matrigel thread in vitro tumor model. In Vitro Cell Dev Biol Anim 31:582-9
Casciari, J J; Rasey, J S (1995) Determination of the radiobiologically hypoxic fraction in multicellular spheroids from data on the uptake of [3H]fluoromisonidazole. Radiat Res 141:28-36

Showing the most recent 10 out of 28 publications